MIR182 and chronic myelogenous leukemia, BCR-ABL1 positive: We undertook a strategy involving transient modulation and CRISPR/Cas9 (clustered regularly interspersed short palindromic repeats)-mediated knockout of the MIR182 locus in CML cells.